Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation.

Israël B, Leest MV, Sedelaar M, Padhani AR, Zámecnik P, Barentsz JO.

Eur Urol. 2019 Nov 23. pii: S0302-2838(19)30823-1. doi: 10.1016/j.eururo.2019.10.024. [Epub ahead of print]

2.

Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.

Stabile A, Dell'Oglio P, De Cobelli F, Esposito A, Gandaglia G, Fossati N, Brembilla G, Cristel G, Cardone G, Deho' F, Losa A, Suardi N, Gaboardi F, Del Maschio A, Montorsi F, Briganti A.

Eur Urol Oncol. 2018 May;1(1):29-36. doi: 10.1016/j.euo.2018.01.002. Epub 2018 May 15.

PMID:
31100225
3.

Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?

Hoffmann R, Logan C, O'Callaghan M, Gormly K, Chan K, Foreman D.

Int Urol Nephrol. 2018 Jan;50(1):13-19. doi: 10.1007/s11255-017-1753-1. Epub 2017 Nov 29.

PMID:
29188489
4.

Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.

Xu L, Zhang G, Shi B, Liu Y, Zou T, Yan W, Xiao Y, Xue H, Feng F, Lei J, Jin Z, Sun H.

Cancer Imaging. 2019 Dec 21;19(1):90. doi: 10.1186/s40644-019-0274-9.

5.

A Prospective Accuracy Study of Prostate Imaging Reporting and Data System Version 2 on Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer With Whole-mount Pathology.

Giannarini G, Girometti R, Crestani A, Rossanese M, Calandriello M, Cereser L, Bednarova S, Battistella C, Sioletic S, Zuiani C, Valotto C, Ficarra V.

Urology. 2019 Jan;123:191-197. doi: 10.1016/j.urology.2018.07.067. Epub 2018 Sep 28.

PMID:
30273613
6.

Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions.

Padhani AR, Weinreb J, Rosenkrantz AB, Villeirs G, Turkbey B, Barentsz J.

Eur Urol. 2019 Mar;75(3):385-396. doi: 10.1016/j.eururo.2018.05.035. Epub 2018 Jun 13.

7.

Prostate MRI based on PI-RADS version 2: how we review and report.

Steiger P, Thoeny HC.

Cancer Imaging. 2016 Apr 11;16:9. doi: 10.1186/s40644-016-0068-2.

8.

Interreader agreement of PI-RADS v. 2 in assessing prostate cancer with multiparametric MRI: A study using whole-mount histology as the standard of reference.

Girometti R, Giannarini G, Greco F, Isola M, Cereser L, Como G, Sioletic S, Pizzolitto S, Crestani A, Ficarra V, Zuiani C.

J Magn Reson Imaging. 2019 Feb;49(2):546-555. doi: 10.1002/jmri.26220. Epub 2018 Sep 5.

PMID:
30187600
9.

Accuracy and Variability of Prostate Multiparametric Magnetic Resonance Imaging Interpretation Using the Prostate Imaging Reporting and Data System: A Blinded Comparison of Radiologists.

Pickersgill NA, Vetter JM, Andriole GL, Shetty AS, Fowler KJ, Mintz AJ, Siegel CL, Kim EH.

Eur Urol Focus. 2018 Oct 13. pii: S2405-4569(18)30301-8. doi: 10.1016/j.euf.2018.10.008. [Epub ahead of print]

PMID:
30327280
10.

The efficiency of multiparametric magnetic resonance imaging (mpMRI) using PI-RADS Version 2 in the diagnosis of clinically significant prostate cancer.

Zhao C, Gao G, Fang D, Li F, Yang X, Wang H, He Q, Wang X.

Clin Imaging. 2016 Sep-Oct;40(5):885-8. doi: 10.1016/j.clinimag.2016.04.010. Epub 2016 Apr 26.

PMID:
27179959
11.

The diagnostic accuracy of multiparametric magnetic resonance imaging before biopsy in the detection of prostate cancer.

Otti VC, Miller C, Powell RJ, Thomas RM, McGrath JS.

BJU Int. 2019 Jan;123(1):82-90. doi: 10.1111/bju.14420. Epub 2018 Jul 26.

12.

Baseline Multiparametric MRI for Selection of Prostate Cancer Patients Suitable for Active Surveillance: Which Features Matter?

Sanguedolce F, Petralia G, Sokhi H, Tagliabue E, Anyamene N, Hellawell G, Padhani AR.

Clin Genitourin Cancer. 2018 Apr;16(2):155-163.e6. doi: 10.1016/j.clgc.2017.10.020. Epub 2017 Nov 21.

PMID:
29198639
13.

Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard.

Schaudinn A, Gawlitza J, Mucha S, Linder N, Franz T, Horn LC, Kahn T, Busse H.

Eur J Radiol. 2019 Jul;116:180-185. doi: 10.1016/j.ejrad.2019.04.012. Epub 2019 May 14.

PMID:
31153562
14.

Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer.

Stabile A, Dell'Oglio P, Gandaglia G, Fossati N, Brembilla G, Cristel G, Dehò F, Scattoni V, Maga T, Losa A, Gaboardi F, Cardone G, Esposito A, De Cobelli F, Del Maschio A, Montorsi F, Briganti A.

Eur Urol Oncol. 2018 Jun;1(2):120-128. doi: 10.1016/j.euo.2018.02.002. Epub 2018 May 15.

PMID:
31100235
15.

What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.

Moldovan PC, Van den Broeck T, Sylvester R, Marconi L, Bellmunt J, van den Bergh RCN, Bolla M, Briers E, Cumberbatch MG, Fossati N, Gross T, Henry AM, Joniau S, van der Kwast TH, Matveev VB, van der Poel HG, De Santis M, Schoots IG, Wiegel T, Yuan CY, Cornford P, Mottet N, Lam TB, Rouvière O.

Eur Urol. 2017 Aug;72(2):250-266. doi: 10.1016/j.eururo.2017.02.026. Epub 2017 Mar 21. Review.

PMID:
28336078
16.

How to make clinical decisions to avoid unnecessary prostate screening in biopsy-naïve men with PI-RADs v2 score ≤ 3?

Zhang Y, Zeng N, Zhang F, Huang Y, Tian Y.

Int J Clin Oncol. 2020 Jan;25(1):175-186. doi: 10.1007/s10147-019-01524-9. Epub 2019 Aug 31.

PMID:
31473884
18.

Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?

Exterkate L, Wegelin O, Barentsz JO, van der Leest MG, Kummer JA, Vreuls W, de Bruin PC, Bosch JLHR, van Melick HHE, Somford DM.

Eur Urol Oncol. 2019 Jun 22. pii: S2588-9311(19)30080-X. doi: 10.1016/j.euo.2019.06.005. [Epub ahead of print]

PMID:
31239236
19.

Biparametric MRI of the prostate.

Scialpi M, D'Andrea A, Martorana E, Malaspina CM, Aisa MC, Napoletano M, Orlandi E, Rondoni V, Scialpi P, Pacchiarini D, Palladino D, Dragone M, Di Renzo G, Simeone A, Bianchi G, Brunese L.

Turk J Urol. 2017 Dec;43(4):401-409. doi: 10.5152/tud.2017.06978. Epub 2017 Dec 1. Review. Erratum in: Turk J Urol. 2018 Jan;44(1):91.

20.

Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 1: Acquisition.

Engels RRM, Israël B, Padhani AR, Barentsz JO.

Eur Urol. 2019 Sep 30. pii: S0302-2838(19)30741-9. doi: 10.1016/j.eururo.2019.09.021. [Epub ahead of print]

Supplemental Content

Support Center